Addressing physician barriers to administering cyclin-dependent kinases 4 and 6 inhibitors in first-line treatment of hormone receptor– positive, human epidermal growth factor receptor 2–negative advanced breast cancer

Research output: Contribution to journalReview article

2 Scopus citations

Fingerprint Dive into the research topics of 'Addressing physician barriers to administering cyclin-dependent kinases 4 and 6 inhibitors in first-line treatment of hormone receptor– positive, human epidermal growth factor receptor 2–negative advanced breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences